Noul
Scope
Date
~
-
Bio & PharmaNoul's miLab registered FDA's Class I
South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said on ...
Nov 28, 2024 (Gmt+09:00)
-
Bio & PharmaNoul, CDC to start Malaria diagnosis project in Kenya
South Korea's Noul Co., an in-vitro diagnostics maker and artificial intelligence (AI)-based blood and cancer diagnostic platforms company, said o...
Jun 18, 2024 (Gmt+09:00)
-
Bio & PharmaNoul to export $1.4 mn in malaria diagnostic kits to Angola
South Korean in-vitro diagnostics maker Noul Co. has signed an exclusive sales deal in Angola on the company’s malaria diagnostic platform wor...
Oct 17, 2023 (Gmt+09:00)
-
Bio & PharmaNoul releases AI-based diagnostic gizmo for cervical cancer
Noul Co., a South Korean company specializing in artificial intelligence (AI)-based blood and cancer diagnostic platforms, has entered the cancer di...
Oct 11, 2023 (Gmt+09:00)
-
Bio & PharmaS.Korean biotech firm Noul signs MOU with disease center of Ghana
South Korea's Medical diagnostics company Noul Co., Ltd. said on Monday that it has signed a memorandum of understanding with the Ghana Infectious D...
Dec 12, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand
